The Financing of Illinois’ Prescription Drug Demonstration Project
This policy brief describes the financing of Illinois' new Medicaid prescription drug waiver.
View the Latest: Medicare Part D
Filter
-
-
Prescription Drug Coverage for Medicare Beneficiaries: A Side-by-Side Comparison
Other PostThis document, prepared by Health Policy Alternatives, Inc., provides a side-by-side comparison of five major federal proposals under consideration to provide outpatient prescription drug coverage to Medicare beneficiaries. It includes both a summary and a detailed comparison of the following major proposals: S. 357, The Medicare Preservation and Improvement Act of 2001 (Breaux/Frist I), S.
-
Medicare Part D 2010 Data Spotlight: Coverage of Top Brand-Name and Specialty Drugs
Issue BriefThis Part D Data Spotlight documents the wide variations across the private stand-alone drug plans with respect to coverage of drugs, what enrollees pay for those drugs, and restrictions and limitations placed on their use. These variations have potentially significant implications for beneficiaries’ access to medications and out-of-pocket costs.
-
Views of the New Medicare Drug Law – Chartpack on People with Disabilities
ReportThis comprehensive survey of people on Medicare, conducted in June and July 2004, assesses their attitudes toward the new Medicare drug law. This chartpack, issued in September 2004, presents additional analysis on the survey data, focusing on the views of people under age 65 with physical and/or mental disabilities. Supplemental Chartpack (.
-
NPR/Kaiser Family Foundation/Harvard Kennedy School of Government Survey on Health Care – Chart Pack
Poll FindingNew NPR/Kaiser Family Foundation/Harvard Kennedy School of Government Survey on Health Care A new survey by NPR, the Kaiser Family Foundation, and Harvard s Kennedy School of Government finds that many Americans have real problems when it comes to accessing and paying for health care, and even if they haven't yet faced a problem, many…
-
Prescription Drug Coverage for Medicare Beneficiaries
Other PostA Side-by-Side Comparison of Selected Proposals as of February 15, 2000 This document provides a side-by-side comparison of five major federal proposals that have been considered to provide outpatient prescription drug coverage to Medicare beneficiaries.
-
Understanding the Health-Care Needs and Experiences of People with Disabilities: Findings from a 2003 Survey
ReportUnderstanding the Health-Care Needs and Experiences of People with Disabilities: Findings from a 2003 Survey People with disabilities are at risk in the health-care system because of their wide-ranging health-care needs, their relatively heavy use of prescription drugs, health-care and support services, and typically low incomes.
-
Survey of People with Disabilities
Poll FindingPeople with disabilities are at risk in the health-care system because of their wide-ranging health-care needs, their relatively heavy use of prescription drugs, health-care and support services, and typically low incomes. A new survey of people with permanent mental and/or physical disabilities explores their health-care experiences and challenges in accessing and paying for care.
-
Explaining the Prescription Drug Provisions in the Build Back Better Act
Issue BriefThe Build Back Better Act includes several provisions that would lower prescription drug costs for people with Medicare and private insurance and reduce drug spending by the federal government and private payers. This brief summarizes these provisions and discusses the expected effects on people, program spending, and drug prices and innovation.
-
Medicare Part D: A First Look at Medicare Prescription Drug Plans in 2021
Issue BriefThis issue brief provides an overview of the Medicare Part D prescription drug benefit plan landscape for 2021, with a focus on stand-alone drug plans. It includes national and state-level data on plan availability, premiums, benefit design, cost sharing, information about premium-free plans for low-income beneficiaries, and information about the national Part D drug plans available in 2021.